Patents Assigned to Takeda Vaccines (Montana), Inc.
  • PURIFICATION OF VIRUS LIKE PARTICLES
    Publication number: 20140004145
    Abstract: Methods of purifying virus-like particles (VLPs) that are substantially free of process contaminants and infectious agents. The methods incorporate, for example, low-pH treatment during harvest and/or inactivation by a solvent and/or detergent during VLP capture.
    Type: Application
    Filed: June 24, 2013
    Publication date: January 2, 2014
    Applicant: Takeda Vaccines (Montana), Inc
    Inventor: Ross TAYLOR
  • Virus like particle purification
    Patent number: 8481693
    Abstract: Methods for purifying human Calciviruses are disclosed, including Noroviruses and Sapoviruses.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: July 9, 2013
    Assignee: Takeda Vaccines (Montana), Inc.
    Inventors: Thomas S. Vedvick, Bryan Steadman, Charles Richardson, Thomas R. Foubert, Charles R. Petrie
  • Norovirus vaccine formulations
    Patent number: 8431116
    Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: April 30, 2013
    Assignee: Takeda Vaccines (Montana), Inc.
    Inventors: Charles Richardson, Thomas S. Vedvick, Thomas R. Foubert, William T. Tino